Join +750K new investors every month who copy stock picks from billionaire's portfoliosSign Up Free

Safety Shot shares climb on promising BAC reduction study results

EditorRachael Rajan
Published 10/12/2023, 03:48 PM
© Reuters.
SHOT
-

Shares of Safety Shot, previously known as Jupiter Wellness, saw an uptick of over 11.77% on Thursday, following the release of a study that suggests its beverage could help reduce blood alcohol concentration (BAC) levels. This recent surge adds to the firm's remarkable annual growth of 123%.

The study, albeit loosely supervised, involved volunteers consuming alcohol for an hour, then pausing for 30 minutes before undergoing sobriety tests and breathalyzer measurements. After the consumption of Safety Shot and another half-hour wait, these tests were repeated. The results indicated that individuals who consumed Safety Shot experienced an average BAC reduction rate of 0.079% per hour. In contrast, the control group's reduction rate stood at only 0.01% per hour.

The beverage in question was procured from GBB Drink Lab in July 2023. Glynn Wilson, Safety Shot's Chief Scientific Officer, announced on Thursday that a double-blinded placebo-controlled clinical trial is underway to generate more credible data regarding the drink's efficacy.

The company's stock performance and the promising initial results from the study have sparked interest among investors and consumers alike. However, the scientific community and market watchers will be keenly awaiting the results of the upcoming clinical trial for more definitive proof of the product's effectiveness.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.